[Holter analysis of ventricular arrhythmias and its treatment with propafenone].
We studied 20 patients with ventricular premature beats. All of them underwent 16-24 hs Holter monitoring before and during propafenone treatment at an average dosage of 600 mgs P.O. We observed 86% decrease in the ectopic beats. In two cases there was a complete abolition of the ventricular beats. The Lown's type 3 ventricular beats had a 50% reduction. The were not significant modifications of the heart rate of blood pressure. There were not significant side effects. We consider propafenone as a potent agent for the treatment of ventricular ectopic beats.
D000328:Adult; D000368:Aged; D005117:Cardiac Complexes, Premature / Q000188:drug therapy* / Q000503:physiopathology; D004341:Drug Evaluation; D004562:Electrocardiography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D011405:Propafenone; D011427:Propiophenones / Q000627:therapeutic use*
D011427:Propiophenones; D011405:Propafenone
Analisis de las arritmias ventriculares con Holter y su tratamiento con propafenona.